These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1753 related articles for article (PubMed ID: 27259866)

  • 41. Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma.
    Tang H; Zhang J; Yu Z; Ye L; Li K; Ding F; Feng X; Meng W
    Technol Cancer Res Treat; 2017 Dec; 16(6):1136-1149. PubMed ID: 29332449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.
    Liu S; Zhang W; Liu K; Ji B; Wang G
    Mol Med Rep; 2015 Jan; 11(1):597-602. PubMed ID: 25323956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells.
    Shi Y; Yan F; Wang F; Pan L
    Tissue Cell; 2021 Oct; 72():101534. PubMed ID: 33991762
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway.
    Gu W; Li X; Wang J
    Oncol Rep; 2014 Jan; 31(1):397-404. PubMed ID: 24190507
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway.
    Lou G; Dong X; Xia C; Ye B; Yan Q; Wu S; Yu Y; Liu F; Zheng M; Chen Z; Liu Y
    J Exp Clin Cancer Res; 2016 Jan; 35():14. PubMed ID: 26790956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long non-coding RNA SUMO1P3 promotes hepatocellular carcinoma progression through activating Wnt/β-catenin signalling pathway by targeting miR-320a.
    Wu S; Chen S; Lin N; Yang J
    J Cell Mol Med; 2020 Mar; 24(5):3108-3116. PubMed ID: 31970876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of circ_0021093 circular RNA forecasts an unfavorable prognosis and facilitates cell progression by targeting the miR-766-3p/MTA3 pathway in hepatocellular carcinoma.
    Liu L; Qi X; Gui Y; Huo H; Yang X; Yang L
    Gene; 2019 Sep; 714():143992. PubMed ID: 31330234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma.
    Wang W; Lin H; Zhou L; Zhu Q; Gao S; Xie H; Liu Z; Xu Z; Wei J; Huang X; Zheng S
    Eur J Surg Oncol; 2014 Nov; 40(11):1586-94. PubMed ID: 24290372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt/β-catenin signaling through targeting BCL9.
    Yao B; Li Y; Wang L; Chen T; Niu Y; Liu Q; Liu Z
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3885-3895. PubMed ID: 31561723
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Upregulating microRNA-373-3p promotes apoptosis and inhibits metastasis of hepatocellular carcinoma cells.
    Li H; Wang N; Xu Y; Chang X; Ke J; Yin J
    Bioengineered; 2022 Jan; 13(1):1304-1319. PubMed ID: 34983307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
    Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.
    Zhao L; Zhang Y
    Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of miR-541-3p/TMPRSS4 in the metastasis and EMT of hepatocellular carcinoma.
    Xia YH; Ren L; Li JZ; Gao F
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10721-10728. PubMed ID: 31858539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CircSLC3A2 functions as an oncogenic factor in hepatocellular carcinoma by sponging miR-490-3p and regulating PPM1F expression.
    Wang H; Chen W; Jin M; Hou L; Chen X; Zhang R; Zhang J; Zhu J
    Mol Cancer; 2018 Nov; 17(1):165. PubMed ID: 30470261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9.
    Yang C; Xu Y; Cheng F; Hu Y; Yang S; Rao J; Wang X
    Cell Death Dis; 2017 Aug; 8(8):e2999. PubMed ID: 28817119
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4.
    Dou C; Liu Z; Xu M; Jia Y; Wang Y; Li Q; Yang W; Zheng X; Tu K; Liu Q
    Cancer Lett; 2016 Oct; 381(2):380-90. PubMed ID: 27544906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-542-3p functions as a tumor suppressor via directly targeting survivin in hepatocellular carcinoma.
    Wang XP; Yao J; Guan J; Zhou ZQ; Zhang ZY; Yang J
    Biomed Pharmacother; 2018 Mar; 99():817-824. PubMed ID: 29710480
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MiR-613 functions as tumor suppressor in hepatocellular carcinoma by targeting YWHAZ.
    Jiang X; Wu J; Zhang Y; Wang S; Yu X; Li R; Huang X
    Gene; 2018 Jun; 659():168-174. PubMed ID: 29551505
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-144 inhibits hepatocellular carcinoma cell proliferation, invasion and migration by targeting ZFX.
    Bao H; Li X; Li H; Xing H; Xu B; Zhang X; Liu Z
    J Biosci; 2017 Mar; 42(1):103-111. PubMed ID: 28229969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 88.